Page last updated: 2024-08-24

brequinar and Breast Neoplasms

brequinar has been researched along with Breast Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Horvat, NK; Lesinski, GB1
Abrams, SI; Amitrano, AM; Barbi, J; Colligan, SH; Kramer, ED; Morreale, B; Nemeth, MJ; Opyrchal, M; Peresie, J; Singh, PK; Sykes, DB; Wang, J; Yu, H; Zollo, RA1
Azarnia, N; Cody, R; Dallaire, B; DeForni, M; Gyves, J; Moore, M; Stewart, D1
Cleaveland, ES; Cooney, DA; Ford, H; Kelley, JA; Paull, K; Zaharevitz, DW1

Trials

1 trial(s) available for brequinar and Breast Neoplasms

ArticleYear
Multicenter phase II study of brequinar sodium in patients with advanced breast cancer.
    American journal of clinical oncology, 1993, Volume: 16, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Biphenyl Compounds; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis

1993

Other Studies

3 other study(ies) available for brequinar and Breast Neoplasms

ArticleYear
Bring on the brequinar: an approach to enforce the differentiation of myeloid-derived suppressor cells.
    The Journal of clinical investigation, 2022, 12-01, Volume: 132, Issue:23

    Topics: Biphenyl Compounds; Breast Neoplasms; Cell Differentiation; Female; Humans; Myeloid-Derived Suppressor Cells

2022
Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression.
    The Journal of clinical investigation, 2022, 12-01, Volume: 132, Issue:23

    Topics: Animals; Breast Neoplasms; Female; Humans; Immunologic Factors; Immunotherapy; Mammary Neoplasms, Animal; Mice; Myeloid-Derived Suppressor Cells; Programmed Cell Death 1 Receptor

2022
Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar.
    Biochemical and biophysical research communications, 1996, Jun-25, Volume: 223, Issue:3

    Topics: Antineoplastic Agents; Aspartic Acid; Biphenyl Compounds; Breast Neoplasms; Carbolines; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Colonic Neoplasms; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Female; Humans; Kidney Neoplasms; Kinetics; Leukemia; Lung Neoplasms; Male; Melanoma; Mitochondria; Orotic Acid; Ovarian Neoplasms; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Prostatic Neoplasms; Ribonucleotides; Sodium Bicarbonate; Software; Tumor Cells, Cultured

1996